Biopol Chemicals Limited (NSE:BIOPOL)
India · Delayed Price · Currency is INR 46.50
0.00 (0.00%)
At close: Nov 13, 2026
Biopol Chemicals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Cash & Equivalents | 1.05 | 5.18 | 11.48 | 0.82 |
Cash & Short-Term Investments | 1.05 | 5.18 | 11.48 | 0.82 |
Cash Growth | - | -54.85% | 1295.26% | - |
Accounts Receivable | 258.76 | 277.87 | 166.56 | 101.31 |
Other Receivables | - | 19.05 | 8.21 | 7.1 |
Receivables | 258.76 | 296.92 | 174.78 | 108.41 |
Inventory | 253.53 | 196.08 | 118.14 | 61.33 |
Prepaid Expenses | - | 0.12 | 0.5 | - |
Other Current Assets | 27.5 | 51.88 | 9.19 | 1.99 |
Total Current Assets | 540.84 | 550.18 | 314.1 | 172.55 |
Property, Plant & Equipment | 248.56 | 143.58 | 2.55 | 2.71 |
Other Intangible Assets | - | 0.04 | 0.03 | 0.01 |
Long-Term Deferred Tax Assets | 0.66 | 0.37 | 0.09 | 0.29 |
Other Long-Term Assets | 1.51 | 3.59 | - | 0.01 |
Total Assets | 831.35 | 697.75 | 316.76 | 175.57 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Accounts Payable | 47.81 | 64.35 | 86.01 | 38.38 |
Accrued Expenses | - | 0.74 | 2.18 | 2.57 |
Short-Term Debt | 132.42 | 15 | 68.13 | 35.77 |
Current Portion of Long-Term Debt | - | 19.09 | 2.33 | - |
Current Income Taxes Payable | - | 43.89 | 14.78 | 2.98 |
Other Current Liabilities | 50.88 | 4.24 | 1.06 | 3.4 |
Total Current Liabilities | 231.12 | 147.31 | 174.47 | 83.09 |
Long-Term Debt | 47.22 | 50.56 | 6.4 | - |
Pension & Post-Retirement Benefits | - | 0.68 | - | 0.46 |
Total Liabilities | 279.08 | 198.54 | 180.88 | 83.56 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Common Stock | 108.05 | 108.05 | 79.11 | 79.11 |
Additional Paid-In Capital | - | 246.02 | 0.89 | 0.89 |
Retained Earnings | - | - | - | 12.01 |
Comprehensive Income & Other | 444.22 | 145.14 | 55.89 | - |
Shareholders' Equity | 552.27 | 499.21 | 135.89 | 92.01 |
Total Liabilities & Equity | 831.35 | 697.75 | 316.76 | 175.57 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Total Debt | 179.64 | 84.65 | 76.85 | 35.77 |
Net Cash (Debt) | -178.59 | -79.47 | -65.37 | -34.94 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | -18.34 | -9.59 | -8.26 | - |
Filing Date Shares Outstanding | 10.81 | 10.81 | 10.81 | - |
Total Common Shares Outstanding | 10.81 | 10.81 | 7.91 | - |
Working Capital | 309.73 | 402.87 | 139.62 | 89.46 |
Book Value Per Share | 51.10 | 46.20 | 17.18 | - |
Tangible Book Value | 552.27 | 499.17 | 135.86 | 92 |
Tangible Book Value Per Share | 51.10 | 46.20 | 17.17 | - |
Land | - | 127.65 | - | - |
Machinery | - | 17.06 | 3.91 | 3.65 |
Construction In Progress | - | 1.2 | - | 0.59 |